Morpholino

MO1-id2a

ID
ZDB-MRPHLNO-101111-5
Name
MO1-id2a
Previous Names
None
Target
Sequence
5' - GCCTTCATGTTGACAGCAGGATTTC - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-id2a
Expressed Gene Anatomy Figures
ascl1a Fig. 3 with image from Uribe et al., 2012
atoh7 Fig. 4 with image from Uribe et al., 2010
ccnd1 Fig. 7 with image from Uribe et al., 2012
cdk6 Fig. 7 with image from Uribe et al., 2012
cdkn1a Fig. 7 with image from Uribe et al., 2012
cdx1b Fig. 3 with image from Khaliq et al., 2015
cp Fig. 3 with image from Khaliq et al., 2015
crx Fig. 4 with image from Uribe et al., 2010
dla Fig. 3 with image from Uribe et al., 2012
dlc Fig. 3 with image from Uribe et al., 2012
dlx2a Fig. 10 with image from Das et al., 2012
fabp10a Fig. 3 with image from Khaliq et al., 2015
fli1 Fig. 10 with image from Das et al., 2012
fzd6 Fig. 7 with image from Uribe et al., 2012
her4.1 Fig. 3 with image from Uribe et al., 2012
hes6 Fig. 3 with image from Uribe et al., 2012
hhex Fig. S13 with image from Xu et al., 2016
Fig. 3 with image from Khaliq et al., 2015
ins Fig. S2 with image from Khaliq et al., 2015
neurod4 Fig. 4 with image from Uribe et al., 2010
notch1a Fig. 3 with image from Uribe et al., 2012
pdx1 Fig. S13 with image from Xu et al., 2016
prox1a Fig. 3 with image from Khaliq et al., 2015
rspo1 Fig. 7 with image from Uribe et al., 2012
selenop2 Fig. 3 with image from Khaliq et al., 2015
skp2 Fig. 7 with image from Uribe et al., 2012
sox10 Fig. 10 with image from Das et al., 2012
tcf7l1b Fig. 7 with image from Uribe et al., 2012
tfap2a Fig. 4 with image from Uribe et al., 2010
Phenotype
Phenotype resulting from MO1-id2a
Phenotype Fish Figures
amacrine cell ab-5e11 labeling absent, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2012
amacrine cell absent, abnormal WT + MO1-id2a Fig. 2 with image,  Fig. 5 with image from Uribe et al., 2012
Fig. 2 with image from Uribe et al., 2010
amacrine cell differentiation arrested, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2012
brain decreased size, abnormal WT + MO1-id2a Fig. 1 with image from Uribe et al., 2010
camera-type eye photoreceptor cell differentiation disrupted, abnormal WT + MO1-id2a Fig. 5 with image from Uribe et al., 2012
Fig. 2 with image from Uribe et al., 2010
embryonic retina morphogenesis in camera-type eye delayed, abnormal WT + MO1-id2a Fig. 4 with image,  Fig. 5 with image from Uribe et al., 2010
eye decreased size, abnormal WT + MO1-id2a Fig. 4 with image from Uribe et al., 2012
Fig. 1 with image,  Fig. 5 with image from Uribe et al., 2010
eye cell decreased amount, abnormal WT + MO1-id2a Fig. 4 with image from Uribe et al., 2012
eye photoreceptor cell differentiation decreased process quality, abnormal WT + MO1-id2a Fig. 1 with image from Uribe et al., 2012
intestinal bulb decreased size, abnormal WT + MO1-id2a Fig. 3 with image from Khaliq et al., 2015
intrahepatic bile duct aggregated, abnormal gz15Tg; um14Tg + MO1-id2a Fig. 3 with image from Khaliq et al., 2015
intrahepatic bile duct decreased branchiness, abnormal gz15Tg; um14Tg + MO1-id2a Fig. 3 with image from Khaliq et al., 2015
intrahepatic bile duct epithelial cell GFP expression decreased amount, abnormal gz15Tg; um14Tg + MO1-id2a Fig. 3 with image from Khaliq et al., 2015
intrahepatic bile duct epithelial cell GFP expression spatial pattern, abnormal gz15Tg; um14Tg + MO1-id2a Fig. 3 with image from Khaliq et al., 2015
liver EGFP expression absent, abnormal jh1Tg; um14Tg + MO1-id2a Fig. 3 with image from Khaliq et al., 2015
liver DsRed expression decreased amount, abnormal gz15Tg + MO1-id2a Fig. S1 with image from Khaliq et al., 2015
liver hhex expression decreased amount, abnormal WT + MO1-id2a Fig. S13 with image from Xu et al., 2016
liver decreased size, abnormal gz15Tg + MO1-id2a Fig. 3 with image,  Fig. S1 with image from Khaliq et al., 2015
liver apoptotic process increased occurrence, abnormal WT + MO1-id2a Fig. 4 with image from Khaliq et al., 2015
liver cell population proliferation decreased occurrence, abnormal s870Tg + MO1-id2a Fig. 4 with image from Khaliq et al., 2015
Muller cell decreased amount, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2010
regulation of neural retina development disrupted, abnormal WT + MO1-id2a Fig. 4 with image from Uribe et al., 2010
retina ccnd1 expression increased amount, abnormal WT + MO1-id2a Fig. 7 with image from Uribe et al., 2012
retina her4.1 expression increased amount, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina skp2 expression increased amount, abnormal WT + MO1-id2a Fig. 7 with image from Uribe et al., 2012
retina notch1a expression increased amount, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina dlc expression increased amount, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina ascl1a expression increased amount, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina fzd6 expression increased amount, abnormal WT + MO1-id2a Fig. 7 with image from Uribe et al., 2012
retina dla expression increased amount, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina hes6 expression increased amount, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina cdk6 expression increased amount, abnormal WT + MO1-id2a Fig. 7 with image from Uribe et al., 2012
retina rspo1 expression increased amount, abnormal WT + MO1-id2a Fig. 7 with image from Uribe et al., 2012
retina cdkn1a expression increased amount, abnormal WT + MO1-id2a Fig. 7 with image from Uribe et al., 2012
retina tcf7l1b expression increased amount, abnormal WT + MO1-id2a Fig. 7 with image from Uribe et al., 2012
retina dla expression increased distribution, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina notch1a expression increased distribution, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina ascl1a expression increased distribution, abnormal WT + MO1-id2a Fig. 3 with image from Uribe et al., 2012
retina cell decreased amount, abnormal WT + MO1-id2a Fig. 1 with image from Uribe et al., 2012
retina cell population proliferation process quality, abnormal WT + MO1-id2a Fig. 1 with image,  Fig. 4 with image from Uribe et al., 2012
retina layer formation disrupted, abnormal WT + MO1-id2a Fig. 1 with image from Uribe et al., 2010
retinal bipolar neuron absent, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2010
retinal bipolar neuron differentiation disrupted, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2010
retinal cone cell zpr-1 labeling absent, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2012
retinal cone cell absent, abnormal WT + MO1-id2a Fig. 2 with image,  Fig. 5 with image from Uribe et al., 2012
Fig. 2 with image from Uribe et al., 2010
retinal cone cell differentiation arrested, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2012
retinal inner nuclear layer unstructured, abnormal WT + MO1-id2a Fig. 1 with image from Uribe et al., 2010
retinal inner nuclear layer cell undifferentiated, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2010
retinal outer nuclear layer unstructured, abnormal WT + MO1-id2a Fig. 1 with image from Uribe et al., 2010
retinal outer nuclear layer cell undifferentiated, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2010
retinal rod cell decreased amount, abnormal WT + MO1-id2a Fig. 2 with image from Uribe et al., 2010
S phase delayed, abnormal WT + MO1-id2a Fig. 5 with image from Uribe et al., 2010
Phenotype of all Fish created by or utilizing MO1-id2a
Phenotype Fish Conditions Figures
retina cell decreased amount, abnormal WT + MO1-id2a control Fig. 1 with image from Uribe et al., 2012
retina rspo1 expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 7 with image from Uribe et al., 2012
retina tcf7l1b expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 7 with image from Uribe et al., 2012
liver hhex expression decreased amount, abnormal WT + MO1-id2a standard conditions Fig. S13 with image from Xu et al., 2016
retina hes6 expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Uribe et al., 2012
brain decreased size, abnormal WT + MO1-id2a standard conditions Fig. 1 with image from Uribe et al., 2010
liver apoptotic process increased occurrence, abnormal WT + MO1-id2a standard conditions Fig. 4 with image from Khaliq et al., 2015
amacrine cell amount, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 2 with image from Uribe et al., 2012
retinal cone cell amount, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 2 with image from Uribe et al., 2012
retina notch1a expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Uribe et al., 2012
retina cell population proliferation process quality, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 1 with image from Uribe et al., 2012
retina dla expression increased distribution, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Uribe et al., 2012
retina her4.1 expression increased amount, abnormal WT + MO1-id2a control Fig. 3 with image from Uribe et al., 2012
retinal inner nuclear layer cell undifferentiated, abnormal WT + MO1-id2a standard conditions Fig. 2 with image from Uribe et al., 2010
S phase delayed, abnormal WT + MO1-id2a standard conditions Fig. 5 with image from Uribe et al., 2010
retina ascl1a expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Uribe et al., 2012
retina dla expression increased amount, abnormal WT + MO1-id2a control Fig. 3 with image from Uribe et al., 2012
Muller cell decreased amount, abnormal WT + MO1-id2a standard conditions Fig. 2 with image from Uribe et al., 2010
amacrine cell absent, abnormal WT + MO1-id2a control Fig. 2 with image,  Fig. 5 with image from Uribe et al., 2012
Fig. 2 with image from Uribe et al., 2010
eye photoreceptor cell differentiation decreased process quality, abnormal WT + MO1-id2a control Fig. 1 with image from Uribe et al., 2012
retina skp2 expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 7 with image from Uribe et al., 2012
retinal cone cell differentiation process quality, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 2 with image from Uribe et al., 2012
retina ascl1a expression increased distribution, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Uribe et al., 2012
retinal cone cell zpr-1 labeling absent, abnormal WT + MO1-id2a control Fig. 2 with image from Uribe et al., 2012
retinal rod cell decreased amount, abnormal WT + MO1-id2a standard conditions Fig. 2 with image from Uribe et al., 2010
regulation of neural retina development disrupted, abnormal WT + MO1-id2a standard conditions Fig. 4 with image from Uribe et al., 2010
eye cell decreased amount, abnormal WT + MO1-id2a standard conditions Fig. 4 with image from Uribe et al., 2012
intestinal bulb decreased size, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
retina cell amount, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 1 with image from Uribe et al., 2012
retina cdkn1a expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 7 with image from Uribe et al., 2012
retina fzd6 expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 7 with image from Uribe et al., 2012
retinal bipolar neuron absent, abnormal WT + MO1-id2a standard conditions Fig. 2 with image from Uribe et al., 2010
retinal cone cell zpr-1 labeling amount, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 2 with image from Uribe et al., 2012
retinal outer nuclear layer cell undifferentiated, abnormal WT + MO1-id2a standard conditions Fig. 2 with image from Uribe et al., 2010
camera-type eye photoreceptor cell differentiation disrupted, abnormal WT + MO1-id2a standard conditions Fig. 5 with image from Uribe et al., 2012
Fig. 2 with image from Uribe et al., 2010
embryonic retina morphogenesis in camera-type eye delayed, abnormal WT + MO1-id2a chemical treatment: 5-bromo-2'-deoxyuridine Fig. 7 with image from Uribe et al., 2010
retina layer formation disrupted, abnormal WT + MO1-id2a standard conditions Fig. 1 with image from Uribe et al., 2010
retina cdk6 expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 7 with image from Uribe et al., 2012
retina ccnd1 expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 7 with image from Uribe et al., 2012
S phase delayed, abnormal WT + MO1-id2a chemical treatment: 5-bromo-2'-deoxyuridine Fig. 7 with image from Uribe et al., 2010
liver decreased size, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
retinal cone cell absent, abnormal WT + MO1-id2a standard conditions Fig. 2 with image,  Fig. 5 with image from Uribe et al., 2012
Fig. 2 with image from Uribe et al., 2010
amacrine cell ab-5e11 labeling amount, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 2 with image from Uribe et al., 2012
retinal bipolar neuron differentiation disrupted, abnormal WT + MO1-id2a standard conditions Fig. 2 with image from Uribe et al., 2010
amacrine cell differentiation process quality, ameliorated WT + MO1-id2a chemical treatment: DAPT Fig. 2 with image from Uribe et al., 2012
embryonic retina morphogenesis in camera-type eye delayed, abnormal WT + MO1-id2a standard conditions Fig. 4 with image,  Fig. 5 with image from Uribe et al., 2010
retina cell population proliferation process quality, abnormal WT + MO1-id2a standard conditions Fig. 1 with image,  Fig. 4 with image from Uribe et al., 2012
retinal outer nuclear layer unstructured, abnormal WT + MO1-id2a standard conditions Fig. 1 with image from Uribe et al., 2010
retina dlc expression increased amount, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Uribe et al., 2012
eye decreased size, abnormal WT + MO1-id2a standard conditions Fig. 4 with image from Uribe et al., 2012
Fig. 1 with image,  Fig. 5 with image from Uribe et al., 2010
retinal cone cell differentiation arrested, abnormal WT + MO1-id2a control Fig. 2 with image from Uribe et al., 2012
retina notch1a expression increased distribution, abnormal WT + MO1-id2a standard conditions Fig. 3 with image from Uribe et al., 2012
amacrine cell ab-5e11 labeling absent, abnormal WT + MO1-id2a control Fig. 2 with image from Uribe et al., 2012
amacrine cell differentiation arrested, abnormal WT + MO1-id2a control Fig. 2 with image from Uribe et al., 2012
retinal inner nuclear layer unstructured, abnormal WT + MO1-id2a standard conditions Fig. 1 with image from Uribe et al., 2010
liver DsRed expression decreased amount, abnormal gz15Tg + MO1-id2a standard conditions Fig. S1 with image from Khaliq et al., 2015
liver decreased size, abnormal gz15Tg + MO1-id2a standard conditions Fig. S1 with image from Khaliq et al., 2015
liver DsRed expression decreased amount, abnormal gz15Tg + MO1-id2a + MO4-tp53 standard conditions Fig. S1 with image from Khaliq et al., 2015
liver decreased size, abnormal gz15Tg + MO1-id2a + MO4-tp53 standard conditions Fig. S1 with image from Khaliq et al., 2015
liver cell population proliferation decreased occurrence, abnormal s870Tg + MO1-id2a standard conditions Fig. 4 with image from Khaliq et al., 2015
intrahepatic bile duct decreased branchiness, abnormal gz15Tg; um14Tg + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
liver decreased size, abnormal gz15Tg; um14Tg + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
intrahepatic bile duct epithelial cell GFP expression decreased amount, abnormal gz15Tg; um14Tg + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
intrahepatic bile duct aggregated, abnormal gz15Tg; um14Tg + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
intrahepatic bile duct epithelial cell GFP expression spatial pattern, abnormal gz15Tg; um14Tg + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
liver EGFP expression absent, abnormal jh1Tg; um14Tg + MO1-id2a standard conditions Fig. 3 with image from Khaliq et al., 2015
intestine pdx1 expression decreased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
intestine hhex expression decreased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
posterior pancreatic bud hhex expression increased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
posterior pancreatic bud pdx1 expression increased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
eye cell amount, ameliorated WT + MO1-id2a + MO1-notch1a standard conditions Fig. 4 with image from Uribe et al., 2012
amacrine cell amount, ameliorated WT + MO1-id2a + MO1-notch1a control Fig. 5 with image from Uribe et al., 2012
camera-type eye photoreceptor cell differentiation process quality, ameliorated WT + MO1-id2a + MO1-notch1a control Fig. 5 with image from Uribe et al., 2012
retinal cone cell amount, ameliorated WT + MO1-id2a + MO1-notch1a control Fig. 5 with image from Uribe et al., 2012
retina cell population proliferation process quality, ameliorated WT + MO1-id2a + MO1-notch1a standard conditions Fig. 4 with image from Uribe et al., 2012
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.